Hereditary ovarian cancer: Heterogeneity in age at onset

Henry T. Lynch, P. Watson, J. F. Lynch, T. A. Conway, M. Fili

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background. Hereditary ovarian cancer (HOC) is heterogeneous, with at least three distinctive syndromes, namely, hereditary site-specific ovarian cancer, hereditary breast-ovarian cancer (HBOC) syndrome, and Lynch syndrome II. Ovarian cancer, in accord with virtually all varieties of adult onset cancer, displays an increasing incidence with advancing age; however, it shows an earlier age of onset in hereditary settings. Methods. Detailed medical and pathology studies were performed on extended ovarian cancer- prone pedigrees, with special attention given to age at ovarian cancer onset. Results. The age of onset of ovarian cancer is heterogeneous, wherein the average age of onset in HBOC is 52 years, in hereditary site-specific ovarian cancer it is 49 years, and in the Lynch syndrome II it is 45 years, in contrast to its occurrence in the general population, at an average age of 59 years. Conclusions. These differences are important for the initiation of surveillance and management strategies. Age of onset of ovarian cancer differences in these several hereditary subsets are less striking than they are in the case of other integral forms of cancer in the respective syndromes, such as the breast in the HBOC syndrome. In addition, the phenomenon of extremely early age of onset of ovarian cancer occurs infrequently in HOC when compared to other forms of cancer, such as the breast in HBOC or the colon in Lynch syndrome II. Knowledge about age of onset heterogeneity in HOC may harbor important clues about etiology, pathogenesis, and cancer control.

Original languageEnglish
Pages (from-to)573-581
Number of pages9
JournalCancer
Volume71
Issue number2 SUPPL.
StatePublished - 1993

Fingerprint

Age of Onset
Ovarian Neoplasms
Lynch Syndrome II
Hereditary Breast and Ovarian Cancer Syndrome
Breast Neoplasms
Neoplasms
Breast
Pedigree
Colonic Neoplasms
Pathology

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Lynch, H. T., Watson, P., Lynch, J. F., Conway, T. A., & Fili, M. (1993). Hereditary ovarian cancer: Heterogeneity in age at onset. Cancer, 71(2 SUPPL.), 573-581.

Hereditary ovarian cancer : Heterogeneity in age at onset. / Lynch, Henry T.; Watson, P.; Lynch, J. F.; Conway, T. A.; Fili, M.

In: Cancer, Vol. 71, No. 2 SUPPL., 1993, p. 573-581.

Research output: Contribution to journalArticle

Lynch, HT, Watson, P, Lynch, JF, Conway, TA & Fili, M 1993, 'Hereditary ovarian cancer: Heterogeneity in age at onset', Cancer, vol. 71, no. 2 SUPPL., pp. 573-581.
Lynch HT, Watson P, Lynch JF, Conway TA, Fili M. Hereditary ovarian cancer: Heterogeneity in age at onset. Cancer. 1993;71(2 SUPPL.):573-581.
Lynch, Henry T. ; Watson, P. ; Lynch, J. F. ; Conway, T. A. ; Fili, M. / Hereditary ovarian cancer : Heterogeneity in age at onset. In: Cancer. 1993 ; Vol. 71, No. 2 SUPPL. pp. 573-581.
@article{8a6e61a79ae44d75a6c468ae7a199f6a,
title = "Hereditary ovarian cancer: Heterogeneity in age at onset",
abstract = "Background. Hereditary ovarian cancer (HOC) is heterogeneous, with at least three distinctive syndromes, namely, hereditary site-specific ovarian cancer, hereditary breast-ovarian cancer (HBOC) syndrome, and Lynch syndrome II. Ovarian cancer, in accord with virtually all varieties of adult onset cancer, displays an increasing incidence with advancing age; however, it shows an earlier age of onset in hereditary settings. Methods. Detailed medical and pathology studies were performed on extended ovarian cancer- prone pedigrees, with special attention given to age at ovarian cancer onset. Results. The age of onset of ovarian cancer is heterogeneous, wherein the average age of onset in HBOC is 52 years, in hereditary site-specific ovarian cancer it is 49 years, and in the Lynch syndrome II it is 45 years, in contrast to its occurrence in the general population, at an average age of 59 years. Conclusions. These differences are important for the initiation of surveillance and management strategies. Age of onset of ovarian cancer differences in these several hereditary subsets are less striking than they are in the case of other integral forms of cancer in the respective syndromes, such as the breast in the HBOC syndrome. In addition, the phenomenon of extremely early age of onset of ovarian cancer occurs infrequently in HOC when compared to other forms of cancer, such as the breast in HBOC or the colon in Lynch syndrome II. Knowledge about age of onset heterogeneity in HOC may harbor important clues about etiology, pathogenesis, and cancer control.",
author = "Lynch, {Henry T.} and P. Watson and Lynch, {J. F.} and Conway, {T. A.} and M. Fili",
year = "1993",
language = "English",
volume = "71",
pages = "573--581",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Hereditary ovarian cancer

T2 - Heterogeneity in age at onset

AU - Lynch, Henry T.

AU - Watson, P.

AU - Lynch, J. F.

AU - Conway, T. A.

AU - Fili, M.

PY - 1993

Y1 - 1993

N2 - Background. Hereditary ovarian cancer (HOC) is heterogeneous, with at least three distinctive syndromes, namely, hereditary site-specific ovarian cancer, hereditary breast-ovarian cancer (HBOC) syndrome, and Lynch syndrome II. Ovarian cancer, in accord with virtually all varieties of adult onset cancer, displays an increasing incidence with advancing age; however, it shows an earlier age of onset in hereditary settings. Methods. Detailed medical and pathology studies were performed on extended ovarian cancer- prone pedigrees, with special attention given to age at ovarian cancer onset. Results. The age of onset of ovarian cancer is heterogeneous, wherein the average age of onset in HBOC is 52 years, in hereditary site-specific ovarian cancer it is 49 years, and in the Lynch syndrome II it is 45 years, in contrast to its occurrence in the general population, at an average age of 59 years. Conclusions. These differences are important for the initiation of surveillance and management strategies. Age of onset of ovarian cancer differences in these several hereditary subsets are less striking than they are in the case of other integral forms of cancer in the respective syndromes, such as the breast in the HBOC syndrome. In addition, the phenomenon of extremely early age of onset of ovarian cancer occurs infrequently in HOC when compared to other forms of cancer, such as the breast in HBOC or the colon in Lynch syndrome II. Knowledge about age of onset heterogeneity in HOC may harbor important clues about etiology, pathogenesis, and cancer control.

AB - Background. Hereditary ovarian cancer (HOC) is heterogeneous, with at least three distinctive syndromes, namely, hereditary site-specific ovarian cancer, hereditary breast-ovarian cancer (HBOC) syndrome, and Lynch syndrome II. Ovarian cancer, in accord with virtually all varieties of adult onset cancer, displays an increasing incidence with advancing age; however, it shows an earlier age of onset in hereditary settings. Methods. Detailed medical and pathology studies were performed on extended ovarian cancer- prone pedigrees, with special attention given to age at ovarian cancer onset. Results. The age of onset of ovarian cancer is heterogeneous, wherein the average age of onset in HBOC is 52 years, in hereditary site-specific ovarian cancer it is 49 years, and in the Lynch syndrome II it is 45 years, in contrast to its occurrence in the general population, at an average age of 59 years. Conclusions. These differences are important for the initiation of surveillance and management strategies. Age of onset of ovarian cancer differences in these several hereditary subsets are less striking than they are in the case of other integral forms of cancer in the respective syndromes, such as the breast in the HBOC syndrome. In addition, the phenomenon of extremely early age of onset of ovarian cancer occurs infrequently in HOC when compared to other forms of cancer, such as the breast in HBOC or the colon in Lynch syndrome II. Knowledge about age of onset heterogeneity in HOC may harbor important clues about etiology, pathogenesis, and cancer control.

UR - http://www.scopus.com/inward/record.url?scp=0027463618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027463618&partnerID=8YFLogxK

M3 - Article

C2 - 8420679

AN - SCOPUS:0027463618

VL - 71

SP - 573

EP - 581

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2 SUPPL.

ER -